Rhythm Pharmaceuticals Inc is a committed biopharmaceutical company that operates globally. It primarily focuses on developing therapies for rare genetic disorders of obesity, directly working towards the improvement of lives impacted by these conditions.
The organisation operates within the biotechnology industry and is renowned for its innovative contributions. Rhythm Pharmaceuticals Inc’s core service revolves around creating state-of-the-art therapeutics, while paving the path towards novel genetic strategies for obesity treatment.
Stay up to date on the share price of RYTM by adding it to your eToro watchlist.